Results
At 30 days 3.2% in the adrenaline group and 2.4% in the placebo group were alive. There was no significant difference in the proportion of patients who survived with favourable outcomes in each group. At the time of hospital discharge, however, severe neurologic impairment had occurred in 31% of the patients in the adrenaline group as against only 17.8% in the placebo group.
Conclusion
In adults with out-of-hospital cardiac arrest whilst the use of adrenaline resulted in a slightly higher rate of 30-day survival those receiving such treatment resulted in nearly twice the rate of survivors with severe neurologic impairment. 
